Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Edwards Lifesciences Corp (EW)  
$28.11 0.04 (0.14%) as of 4:30 Wed 3/27


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 623,250,000
Market Cap: 17.52(B)
Last Volume: 1,481,256 Avg Vol: 1,477,032
52 Week Range: $27.6017 - $31.53
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Appliances & Equipment

Member Indexes:

    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 400 MIDCAP

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  1033
Guru Rank Value     : -0.5
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Edwards Lifesciences is focused on technologies that treat structural heart disease and ill patients. The products and technologies provided by Co. are categorized into the several main areas, including: Transcatheter Aortic Valve Replacement, which is engaged in transcatheter heart valve replacement technologies designed for the minimally-invasive replacement of aortic heart valves; Transcatheter Mitral and Tricuspid Therapies, which is focused on the development of transcatheter heart valve repair and replacement technologies designed to treat mitral and tricuspid valve diseases; and Surgical Structural Heart, which is engaged in resilient surgical therapies.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 246,209 417,747 881,497 1,438,967
Total Sell Value $20,742,320 $32,745,167 $72,383,369 $124,285,743
Total People Sold 10 11 11 14
Total Sell Transactions 17 32 65 117
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 2814
  Page 1 of 113  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Bobo Donald E Jr CVP,Strategy/Corp Development   •       •      –    2024-03-13 4 AS $91.01 $1,319,696 D/D (14,500) 39,503 -1%     
   Bobo Donald E Jr CVP,Strategy/Corp Development   •       •      –    2024-03-13 4 OE $36.75 $532,875 D/D 14,500 54,003     -
   Lemercier Jean-Luc M CVP, EMEACLA and JAPAC   •       •      –    2024-03-11 4 AS $91.68 $1,320,149 D/D (14,400) 173,584 -1%     
   Lemercier Jean-Luc M CVP, EMEACLA and JAPAC   •       •      –    2024-03-11 4 OE $36.75 $529,200 D/D 14,400 187,984     -
   Lippis Daniel J. CVP, JAPAC   •       •      –    2024-03-07 4 AS $90.98 $156,031 D/D (1,715) 17,213 -1%     
   Lippis Daniel J. CVP, JAPAC   •       •      –    2024-03-07 4 OE $36.75 $63,026 D/D 1,715 18,928     -
   Mussallem Michael A Director   •       •      –    2024-03-04 4 AS $86.21 $2,543,737 D/D (29,350) 4,486 -0%     
   Mussallem Michael A Director   •       •      –    2024-03-04 4 OE $36.75 $1,078,613 D/D 29,350 33,836     -
   Ullem Scott B. CVP, Chief Financial Officer   •       •      –    2024-02-29 4 AS $85.59 $620,923 D/D (7,255) 19,074 1%     
   Ullem Scott B. CVP, Chief Financial Officer   •       •      –    2024-02-29 4 OE $36.75 $266,621 D/D 7,255 26,329     -
   Gallahue Kieran Director   •       •      –    2024-02-23 4 S $87.61 $267,911 I/I (3,058) 67,219 -1%     
   Gallahue Kieran Director   •       •      –    2024-02-23 4 GA $0.00 $0 I/I 7,056 70,277     -
   Gallahue Kieran Director   •       •      –    2024-02-23 4 GD $0.00 $0 D/D 7,056 3,701     -
   Gallahue Kieran Director   •       •      –    2024-02-23 4 OE $36.86 $260,107 D/D 7,056 10,757     -
   Sellers Robert W.a. SVP, Corporate Controller   •       •      –    2024-02-22 4 A $0.00 $0 D/D 1,998 15,085     -
   Szyman Catherine M CVP, Critical Care   •       •      –    2024-02-22 4 A $0.00 $0 D/D 8,560 43,374     -
   Chopra Daveen CVP, TMTT   •       •      –    2024-02-21 4 S $86.67 $711,272 D/D (8,200) 22,750 -1%     
   Chopra Daveen CVP, TMTT   •       •      –    2024-02-21 4 OE $59.26 $414,797 D/D 7,000 30,950     -
   Lippis Daniel J. CVP, JAPAC   •       •      –    2024-02-18 4 D $86.10 $16,187 D/D (188) 17,213     -
   Lippis Daniel J. CVP, JAPAC   •       •      –    2024-02-17 4 D $86.10 $12,915 D/D (150) 17,401     -
   Lippis Daniel J. CVP, JAPAC   •       •      –    2024-02-16 4 D $86.04 $17,810 D/D (207) 17,551     -
   Wood Larry L Global President TAVR & Surg   •       •      –    2024-02-16 4 D $86.04 $27,275 D/D (317) 213,477     -
   Ullem Scott B. CVP, Chief Financial Officer   •       •      –    2024-02-16 4 D $86.04 $14,971 D/D (174) 19,074     -
   Szyman Catherine M CVP, Critical Care   •       •      –    2024-02-15 4 S $85.62 $2,311,654 D/D (27,000) 34,814 -1%     
   Szyman Catherine M CVP, Critical Care   •       •      –    2024-02-15 4 OE $36.75 $992,250 D/D 27,000 61,814     -

  2814 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 113
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed